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biopsy. The present case stresses the importance of accurate appearance of peripheral lymph node enlargement, facial peripheral evaluation of skin lesions in the diagnosis of some haematological paralysis and claudication of upper and lower extremities, which was conditions and gives additional information about T-PLL such considered as consistent with central nervous system involvement as a previously non-reported cytogenetic abnormality [t(6;6)] by the disease. Cytospin of the cerebrospinal fluid was normal.
and lack of cutaneous lymphocytic-associated antigen expres-
Electromyography detected mixed axonal and radicular polyneuropa-
sion. Key words: Cutaneous lymphocytic-associated (CLA)
thy, and a sural nerve biopsy showed infiltration by prolymphocytes.
antigen; immunophenotyping; skin biopsy; T-cell leukaemia.
The patient was subsequently given CHOP (cyclophosphamide, (Accepted August 26, 1997.) Acta Derm Venereol (Stockh) 1998; 78: 198-200. A. Serra, Department of Hematology, Hospital Clínic, Villarroel 170, E-08036 Barcelona, Spain.
Prolymphocytic leukaemia (PLL) is a rare chronic lymphoproliferative disease that originates in B-lymphocytes in more than 80% of cases and in T-lymphocytes in about 20% of cases (1, 2) . The clinical course of the disease is usually aggressive, with little or no response to therapy (2) . T-cell PLL ( T-PLL) is the most common of all mature T-cell leukaemias in adults, accounting for over 30% (2) . Other mature T-cell malignancies include large granular lymphocytic leukaemia and leukaemia/lymphoma syndromes such as adult T-cell leukaemia/ lymphoma (ATLL), cutaneous T-cell lymphoma and peripheral non-cutaneous T-cell non-Hodgkin's lymphoma. In contrast to B-cell lymphoproliferative disorders, T-cell malignancies show a tendency to specific cutaneous involvement. Thus, whereas skin infiltration is seen in less than 5% of B-cell malignancies, in T-cell disorders it ranges from 10% to 100% (3). We report a case of T-PLL with skin lesion as the first manifestation.
CASE REPORT
A 73-year-old woman was referred to the Dermatology Department in March 1995 with a 1-month history of a cellulitis-like lesion on the right leg ( Fig. 1 ). Resistant to antibiotic therapy, the lesion rapidly enlarged to an erythematous plaque 20×10 cm in size with multiple indurated nodules on its surface. Lymphaedema of the involved leg was also observed. General physical examination revealed hepatomegaly, splenomegaly and generalized lymphadenopathy. The WBC count was 188×109/l with 99% prolymphocytes. The platelet count was 117×109/l and the Hb concentration was normal. Serum lactate Fig. 2 . Typical prolymphocytes from bone marrow of patient (Maydehydrogenase was 709 IU/l (normal values: 250-450 IU/l ). The bone marrow showed increased cellularity with a 70% infiltration by proGrü nwald-Giemsa ×1000). 
by direct immunofluorescence, with the exception of cytoplasmic detection of CD3 and TCR a/b, which was carried out using the Fig. 3 . Non-epidermotropic dermal and hipodermal infiltration by alkaline phosphatase antialkaline phosphatase method (APAAP), and medium-size T-PLL cells (Hematoxylin-eosin ×100).
CLA antigen, which was investigated by immunohistochemistry (indirect immunoperoxidase method) on peripheral blood smears. The doxorubicin, vincristine, prednisone) as well as intrathecal methotrexresults were: CD2+, CD4+, CD7+, CD5+, CD3 cyt +(100%), but ate and cytarabine, but she did not improve. She eventually died a CD3 s -(2%), CD8-, TdT-, CD1-, CD16-, CD56-, CD57-, TCR a/bfew weeks later, 10 months after presentation.
(surface and cytoplasmic), TCR c/d-, CD19-, HLA-DR-, CD25-, CD30-. CLA antigen was also negative ( Table I ) .
Cutaneous light microscopy
Histopathological examination of a skin biopsy showed a normal epidermis and a preserved Grenz zone. A dense and diffuse lymphoid DISCUSSION infiltrate was present in the upper and lower dermis, extending to the T-PLL is characterized by a high tumour mass with marked subcutaneous tissue. It was composed of small-and medium-sized leukocytosis, hepatosplenomegaly and lymphadenopathy.
lymphoid cells with rounded nucleus without cerebriform features and Cutaneous involvement, which occurs in about a quarter of with a prominent nucleolus ( Fig. 3). patients (3), is usually present at the time of diagnosis (e.g.
Cutaneous immunohistochemistry
88% in the series reported by Matutes et al. (2) 
Skin biopsies of T-PLL cutaneous involvement show a
Inmunohistochemistry methods employed were avidin-biotin-alkaline normal epidermis and a dermal infiltrate concentrated around phosphatase for antigens investigated on paraffin-embedded tissue and blood vessels and appendages without involving them. In some avidin-biotin-peroxidase for antigens investigated on frozen tissue, cases the infiltrate extends to subcutaneous fat, as it did in with the exception of the CLA antigen which was studied by an our case. Epidermotropism has never been described (2, 3) .
indirect peroxidase method using a goat anti-rat IgM as secondary
The lymphoid cells which compose the infiltrate have a prominantibody ( Table I ) . ent nucleolus similar to the cells in peripheral blood.
Regarding the immunophenotype of T-PLL in 65-70% of
Peripheral blood immunophenotyping
the cases is CD4+ CD8-, and in 15-20% CD4+ and CD8+
The immunophenotype of circulating leukaemic cells was studied with a three-channel fluorescence cytometer (FACScan, Becton Dickinson) (2, 3 To the best of our knowledge, CLA expression by T-PLL cells has not been previously investigated. Although positivity for CLA seems to be variable in non-cutaneous T-cell lymphoproliferative disorders (5), the absence of this skin-related REFERENCES adhesion molecule could be a useful feature in the study of a
